Insider Transactions in Q3 2018 at Unitedhealth Group Inc (UNH)
Insider Transaction List (Q3 2018)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 26
2018
|
Richard T Burke Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.29%
|
$125,000
$25.08 P/Share
|
Sep 18
2018
|
William C Ballard Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
79
+0.11%
|
-
|
Sep 18
2018
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
79
+0.0%
|
-
|
Sep 18
2018
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.36%
|
-
|
Sep 18
2018
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
101
+0.31%
|
-
|
Sep 18
2018
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.41%
|
-
|
Sep 18
2018
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.41%
|
-
|
Sep 18
2018
|
Glenn M Renwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
149
+0.19%
|
-
|
Sep 18
2018
|
Kenneth Irwin Shine Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.34%
|
-
|
Sep 18
2018
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
73
+0.12%
|
-
|
Sep 18
2018
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
415
+0.02%
|
-
|
Sep 18
2018
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.1%
|
-
|
Sep 18
2018
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
67
+0.26%
|
-
|
Sep 18
2018
|
Marianne D Short EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
79
+0.08%
|
-
|
Sep 18
2018
|
David S Wichmann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
124
+0.02%
|
-
|
Sep 18
2018
|
D Ellen Wilson Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.14%
|
-
|
Sep 18
2018
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
169
+0.34%
|
-
|
Sep 18
2018
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
62
+0.27%
|
-
|
Sep 13
2018
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
SELL
Open market or private sale
|
Direct |
8,142
-26.57%
|
$2,157,630
$265.0 P/Share
|
Sep 13
2018
|
Richard T Burke Director |
SELL
Open market or private sale
|
Direct |
10,000
-0.58%
|
$2,640,000
$264.9 P/Share
|
Sep 13
2018
|
Michele J Hooper Director |
SELL
Open market or private sale
|
Direct |
5,000
-13.2%
|
$1,320,000
$264.86 P/Share
|
Sep 13
2018
|
Michele J Hooper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.66%
|
$125,000
$25.16 P/Share
|
Sep 12
2018
|
Richard T Burke Director |
SELL
Open market or private sale
|
Direct |
20,000
-1.15%
|
$5,260,000
$263.41 P/Share
|
Sep 12
2018
|
Gail R Wilensky |
SELL
Open market or private sale
|
Direct |
5,740
-8.84%
|
$1,509,620
$263.45 P/Share
|
Sep 12
2018
|
Gail R Wilensky |
BUY
Exercise of conversion of derivative security
|
Direct |
5,740
+4.18%
|
$132,020
$23.76 P/Share
|
Sep 07
2018
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
SELL
Open market or private sale
|
Direct |
26,033
-45.94%
|
$7,028,910
$270.65 P/Share
|
Sep 07
2018
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
BUY
Exercise of conversion of derivative security
|
Direct |
38,249
+19.21%
|
$4,283,888
$112.67 P/Share
|
Aug 24
2018
|
D Ellen Wilson Executive Vice President |
SELL
Open market or private sale
|
Direct |
15,393
-23.18%
|
$4,063,752
$264.29 P/Share
|
Aug 24
2018
|
D Ellen Wilson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+21.33%
|
$1,026,000
$57.38 P/Share
|
Aug 15
2018
|
David S Wichmann Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
473
-0.06%
|
$122,980
$260.61 P/Share
|
Aug 08
2018
|
William C Ballard Jr Director |
SELL
Open market or private sale
|
Direct |
10,000
-6.48%
|
$2,580,000
$258.83 P/Share
|
Aug 08
2018
|
William C Ballard Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.08%
|
$260,000
$26.34 P/Share
|
Aug 01
2018
|
Richard T Burke Director |
SELL
Open market or private sale
|
Direct |
15,000
-0.85%
|
$3,810,000
$254.79 P/Share
|
Jul 18
2018
|
Kenneth Irwin Shine Director |
SELL
Open market or private sale
|
Direct |
177
-0.61%
|
$45,135
$255.72 P/Share
|
Jul 18
2018
|
Gail R Wilensky |
SELL
Open market or private sale
|
Direct |
3,090
-4.96%
|
$778,680
$252.1 P/Share
|
Jul 18
2018
|
Gail R Wilensky |
BUY
Exercise of conversion of derivative security
|
Direct |
890
+1.41%
|
$24,030
$27.02 P/Share
|
Jul 17
2018
|
Richard T Burke Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,780
+0.1%
|
$48,060
$27.02 P/Share
|
Jul 02
2018
|
William C Ballard Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.24%
|
-
|
Jul 02
2018
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.01%
|
-
|
Jul 02
2018
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
304
+12.2%
|
-
|
Jul 02
2018
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.54%
|
-
|
Jul 02
2018
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
304
+38.48%
|
-
|
Jul 02
2018
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+19.69%
|
-
|
Jul 02
2018
|
Glenn M Renwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
329
+0.41%
|
-
|
Jul 02
2018
|
Kenneth Irwin Shine Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.6%
|
-
|
Jul 02
2018
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.29%
|
-
|